N-[4-Methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-4-chloromethyl benzamide
CAS: 404844-11-7
Rif. 3D-FM25665
1mg | Fuori produzione | ||
2mg | Fuori produzione | ||
5mg | Fuori produzione | ||
10mg | Fuori produzione | ||
25mg | Fuori produzione |
Informazioni sul prodotto
- 4-Chloromethyl-N-[4-methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]phenyl]benzamideN-[5[[4-(Chloromethyl)benzoyl]amino]-2-methylph enyl]4-(3-pyridyl)-2-pyrimidine
- N-[5-[[4-(Chloromethyl)benzoyl]amino]-2-methylphenyl]-4-(3-pyridyl)-2-pyrimidineamine
- Chloromethyl-N-[4-methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]phenyl]benzamide
- 4-(chloromethyl)-N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)benzamide
N-[4-Methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-4-chloromethyl benzamide is a synthetic drug that stimulates the release of vasopressin from the posterior pituitary gland. It has been successfully used to treat diabetes insipidus, nocturia, and enuresis. The drug was approved for use in the United States in 1998 and is marketed under the trade name DDAVP.